Breaking Down Solid Tumor Barriers with a Novel Bispecific T-Cell Engager Against a Novel pHLA Target
Time: 12:45 pm
day: Day 1
Details:
• Leveraging the 3T-TRACE platform to screen TCR and TCR mimetic molecules for specific and off-target cross-reactivities
• Building highly specific and safe TCRs for shared targets to effectively treat solid tumors